An Active Lifestyle Is Associated with Better Cognitive Function Over Time in APOE ɛ4 Non-Carriers.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2021
Historique:
pubmed: 12 1 2021
medline: 18 9 2021
entrez: 11 1 2021
Statut: ppublish

Résumé

Available evidence on the association of physical activity (PA) or sedentary behavior with cognitive decline is inconclusive. To assess the association between an active lifestyle score and leisure-time physical activity (LTPA) and changes in cognitive function in the Seguimiento Universidad de Navarra (SUN) prospective cohort. Cognitive function was evaluated in a subsample of 806 participants of the SUN cohort study using the validated Telephone Interview for Cognitive Status-modified (STICS-m) questionnaire at baseline and after 6 years. LTPA was evaluated with a previously validated 17-item self-administered questionnaire and with information on sedentary lifestyles. We also calculated a multidimensional 8-item PA score. Multivariable linear regression analysis evaluated the association between PA and changes in cognitive function and its interaction by APOE genotype. Mean age of participants was 66 (SD 5.3) years and 69.7% were male. When stratifying by APOE variants, no significant associations between the active lifestyle score or LTPA and changes in cognitive performance over time were found among APOE ɛ4 carriers. However, we observed that a higher adherence to an active lifestyle (high versus low PA score β= 0.76 95% CI 0.15,1.36; p trend = 0.011) and a high LTPA (Q4 versus Q1 β= 0.63; 95% CI -0.01,1.26; p trend = 0.030) were associated with more favorable changes in cognitive function over time among APOE ɛ4 non-carriers with statistically significant interactions in both cases (p for interaction = 0.042 for PA score, and p = 0.039 for LTPA). The results of the present study suggest that an active lifestyle is associated with a better status of cognitive function over time only among APOE ɛ4 non-carriers.

Sections du résumé

BACKGROUND
Available evidence on the association of physical activity (PA) or sedentary behavior with cognitive decline is inconclusive.
OBJECTIVE
To assess the association between an active lifestyle score and leisure-time physical activity (LTPA) and changes in cognitive function in the Seguimiento Universidad de Navarra (SUN) prospective cohort.
METHODS
Cognitive function was evaluated in a subsample of 806 participants of the SUN cohort study using the validated Telephone Interview for Cognitive Status-modified (STICS-m) questionnaire at baseline and after 6 years. LTPA was evaluated with a previously validated 17-item self-administered questionnaire and with information on sedentary lifestyles. We also calculated a multidimensional 8-item PA score. Multivariable linear regression analysis evaluated the association between PA and changes in cognitive function and its interaction by APOE genotype.
RESULTS
Mean age of participants was 66 (SD 5.3) years and 69.7% were male. When stratifying by APOE variants, no significant associations between the active lifestyle score or LTPA and changes in cognitive performance over time were found among APOE ɛ4 carriers. However, we observed that a higher adherence to an active lifestyle (high versus low PA score β= 0.76 95% CI 0.15,1.36; p trend = 0.011) and a high LTPA (Q4 versus Q1 β= 0.63; 95% CI -0.01,1.26; p trend = 0.030) were associated with more favorable changes in cognitive function over time among APOE ɛ4 non-carriers with statistically significant interactions in both cases (p for interaction = 0.042 for PA score, and p = 0.039 for LTPA).
CONCLUSION
The results of the present study suggest that an active lifestyle is associated with a better status of cognitive function over time only among APOE ɛ4 non-carriers.

Identifiants

pubmed: 33427740
pii: JAD201090
doi: 10.3233/JAD-201090
doi:

Substances chimiques

Apolipoprotein E4 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1257-1268

Auteurs

Marta Fernández-Matarrubia (M)

Department of Neurology, Clínica Universidad de Navarra, Pamplona, Spain.
IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.

Leticia Goni (L)

IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
Department of Preventive Medicine and Public Health, University of Navarra, Pamplona, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.

Teresa Rognoni (T)

Department of Neurology, Clínica Universidad de Navarra, Madrid, Spain.

Cristina Razquin (C)

IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
Department of Preventive Medicine and Public Health, University of Navarra, Pamplona, Spain.

César Ignacio Fernández-Lázaro (CI)

IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
Department of Preventive Medicine and Public Health, University of Navarra, Pamplona, Spain.

Maira Bes-Rastrollo (M)

IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
Department of Preventive Medicine and Public Health, University of Navarra, Pamplona, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.

Miguel Ángel Martínez-González (MÁ)

IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
Department of Preventive Medicine and Public Health, University of Navarra, Pamplona, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Estefanía Toledo (E)

IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
Department of Preventive Medicine and Public Health, University of Navarra, Pamplona, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH